scholarly journals The role of ubiquitin-specific peptidases in glioma progression

2022 ◽  
Vol 146 ◽  
pp. 112585
Author(s):  
Wulong Liang ◽  
Jia Fang ◽  
Shaolong Zhou ◽  
Weihua Hu ◽  
Zhuo Yang ◽  
...  
Keyword(s):  
1996 ◽  
Vol 104 (1) ◽  
pp. 121-126 ◽  
Author(s):  
Marupudi Sivaparvathi ◽  
Raymond Sawaya ◽  
Ziya L. Gokaslan ◽  
Kumar S. Chintala ◽  
Jasti S. Rao

2018 ◽  
Vol 60 ◽  
pp. 38-51 ◽  
Author(s):  
Claudia Quezada ◽  
Ángelo Torres ◽  
Ignacio Niechi ◽  
Daniel Uribe ◽  
Susana Contreras-Duarte ◽  
...  

2020 ◽  
Vol 11 (12) ◽  
Author(s):  
Haiping Cai ◽  
Yanjiao Yu ◽  
Xiangrong Ni ◽  
Cong Li ◽  
Yuanjun Hu ◽  
...  

AbstractLong noncoding RNAs (lncRNAs), once considered to be nonfunctional relics of evolution, are emerging as essential genes in tumor progression. However, the function and underlying mechanisms of lncRNAs in glioma remain unclear. This study aimed to investigate the role of LINC00998 in glioma progression. Through screening using TCGA database, we found that LINC00998 was downregulated in glioblastoma tissues and that low expression of LINC00998 was associated with poor prognosis. Overexpression of LINC00998 inhibited glioma cell proliferation in vitro and in vivo and blocked the G1/S cell cycle transition, which exerted a tumor-suppressive effect on glioma progression. Mechanistically, RNA pull-down and mass spectrometry results showed an interaction between LINC00998 and CBX3. IP assays demonstrated that LINC00998 could stabilize CBX3 and prevent its ubiquitination degradation. GSEA indicated that LINC00998 could regulate the c-Met/Akt/mTOR signaling pathway, which was further confirmed by a rescue assay using siRNA-mediated knockdown of CBX3 and the Akt inhibitor MK2206. In addition, dual-luciferase assays showed that miR-34c-5p could directly bind to LINC00998 and downregulate its expression. Our results identified LINC00998 as a novel tumor suppressor in glioma, and LINC00998 could be a novel prognostic biomarker, providing a strategy for precision therapy in glioma patients.


2016 ◽  
Vol 61 ◽  
pp. S88-S89
Author(s):  
P. Filppu ◽  
V. Le Joncour ◽  
M. Hyvönen ◽  
H. Sihto ◽  
H. Joensuu ◽  
...  
Keyword(s):  

1996 ◽  
Vol 55 (5) ◽  
pp. 639
Author(s):  
P. Kleihues ◽  
K. Wnlanabe ◽  
O. Tachibana ◽  
H. Ohgaki
Keyword(s):  

Author(s):  
Rashmi Rana ◽  
Shikha Joon ◽  
Kirti Chauhan ◽  
Vaishnavi Rathi ◽  
Nirmal Kumar Ganguly ◽  
...  

: Glioma predominantly targets glial cells in the brain and spinal cord. There are grade I, II, III, and IV gliomas with anaplastic astrocytoma and glioblastoma multiforme as the most severe forms of the disease. Current diagnostic methods are limited in their data acquisition and interpretation, markedly affecting treatment modalities and patient outcomes. Circulating extracellular vesicles (EVs) or “magic bullets” contain bioactive signature molecules such as DNA, RNA, proteins, lipids, and metabolites. These secretory “smart probes” participate in myriad cellular activities, including glioma progression. EVs are released by all cell populations and may serve as novel diagnostic biomarkers and efficient nanovehicles in the targeted delivery of encapsulated therapeutics. The present review describes the potential of EVbased biomarkers for glioma management.


2018 ◽  
Vol 414 ◽  
pp. 81-87 ◽  
Author(s):  
Efthalia Angelopoulou ◽  
Christina Piperi
Keyword(s):  

Author(s):  
Chenyu Ding ◽  
Zanyi Wu ◽  
Honghai You ◽  
Hongliang Ge ◽  
Shufa Zheng ◽  
...  

Abstract Background Circular RNA nuclear factor I X (circNFIX) has been reported to play an important role in glioma progression. However, the mechanism by which circNFIX participates in glioma progression remains poorly understood. Methods GERIA online were used to analyze the abnormally expressed genes in glioma tissues. The expression levels of circNFIX, microRNA (miR)-378e and Ribophorin-II (RPN2) were measured by quantitative real-time polymerase chain reaction or western blot. Cell cycle distribution, apoptosis, glycolysis, migration and invasion were determined by flow cytometry, special kit and trans-well assays, respectively. The target association between miR-378e and circNFIX or RPN2 was confirmed by luciferase reporter assay, RNA immunoprecipitation and pull-down. Xenograft model was established to investigate the role of circNFIX in vivo. Results The expression of circNFIX was enhanced in glioma tissues and cells compared with matched controls and high expression of circNFIX indicated poor outcomes of patients. Knockdown of circNFIX led to arrest of cell cycle, inhibition of glycolysis, migration and invasion and promotion of apoptosis in glioma cells. circNFIX was a sponge of miR-378e. miR-378e overexpression suppressed cell cycle process, glycolysis, migration and invasion but promoted apoptosis. miR-378e silence abated the suppressive role of circNFIX knockdown in glioma progression. RPN2 as a target of miR-378e was positively regulated via circNFIX by competitively sponging miR-378e. Silencing circNFIX decreased glioma xenograft tumor growth by regulating miR-378e/RPN2 axis. Conclusion Knockdown of circNFIX inhibits progression of glioma in vitro and in vivo by increasing miR-378e and decreasing RPN2, providing a novel mechanism for understanding the pathogenesis of glioma.


Sign in / Sign up

Export Citation Format

Share Document